US Aerospace Big Data Analytics Market

ID: MRFR/AD/16624-HCR
100 Pages
Abbas Raut
Last Updated: April 06, 2026
US Aerospace Big Data Analytics Market Size, Share, Industry Trend & Analysis Research Report: By Solution (Predictive Maintenance, Vehicle & Performance Tracking, Weather Forecasting, Route Planning, Aftermarket, Others), By Deployment Mode (On-Premise, On-Demand), By Application (Defense, Commercial Aerospace, Space) andBy Technology (Apps & Analytics, Cloud, Computer, Infrastructure Software, Networking, NoSQL, Professional Services, SQL, Storage)- Forecast to 2035
US Aerospace Big Data Analytics Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)4.04%
2024 Market Size$ 7.12 Billion
2025 Market Size$ 7.4 Billion
2035 Market Size$ 11 Billion
Key Players
Boeing
Lockheed Martin
Northrop Grumman
Raytheon Technologies
Airbus
Thales Group
Trends
  • Increased Adoption of Predictive Analytics
  • Enhanced Data Security Measures
  • Integration of IoT with Data Analytics
Opportunities
  • Emergence of Smart Aircraft Technologies
  • Growing Demand for Operational Efficiency
  • Advancements in Machine Learning Technologies
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Solution (USD Billion)
      1. 4.1.1 Predictive Maintenance
      2. 4.1.2 Vehicle & Performance Tracking
      3. 4.1.3 Weather Forecasting
      4. 4.1.4 Route Planning
      5. 4.1.5 Aftermarket
      6. 4.1.6 Others
    2. 4.2 Pharmaceutical, BY Deployment Mode (USD Billion)
      1. 4.2.1 On-Premise
      2. 4.2.2 On-Demand
    3. 4.3 Pharmaceutical, BY Application (USD Billion)
      1. 4.3.1 Defense
      2. 4.3.2 Commercial Aerospace
      3. 4.3.3 Space
    4. 4.4 Pharmaceutical, BY Technology (USD Billion)
      1. 4.4.1 Apps & Analytics
      2. 4.4.2 Cloud
      3. 4.4.3 Computer
      4. 4.4.4 Infrastructure Software
      5. 4.4.5 Networking
      6. 4.4.6 NoSQL
      7. 4.4.7 Professional Services
      8. 4.4.8 SQL
      9. 4.4.9 Storage
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Boeing (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Lockheed Martin (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Northrop Grumman (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Raytheon Technologies (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Airbus (FR)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Thales Group (FR)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 General Dynamics (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Honeywell (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 L3Harris Technologies (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
      10. 5.2.10 SAAB (SE)
        1. 5.2.10.1 Financial Overview
        2. 5.2.10.2 Products Offered
        3. 5.2.10.3 Key Developments
        4. 5.2.10.4 SWOT Analysis
        5. 5.2.10.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY SOLUTION
    3. 6.3 US MARKET ANALYSIS BY DEPLOYMENT MODE
    4. 6.4 US MARKET ANALYSIS BY APPLICATION
    5. 6.5 US MARKET ANALYSIS BY TECHNOLOGY
    6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
    9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    12. 6.12 PHARMACEUTICAL, BY SOLUTION, 2024 (% SHARE)
    13. 6.13 PHARMACEUTICAL, BY SOLUTION, 2024 TO 2035 (USD Billion)
    14. 6.14 PHARMACEUTICAL, BY DEPLOYMENT MODE, 2024 (% SHARE)
    15. 6.15 PHARMACEUTICAL, BY DEPLOYMENT MODE, 2024 TO 2035 (USD Billion)
    16. 6.16 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
    17. 6.17 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Billion)
    18. 6.18 PHARMACEUTICAL, BY TECHNOLOGY, 2024 (% SHARE)
    19. 6.19 PHARMACEUTICAL, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY SOLUTION, 2025-2035 (USD Billion)
      2. 7.2.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
      3. 7.2.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.2.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Pharmaceutical Market Segmentation

Pharmaceutical By Solution (USD Billion, 2025-2035)

  • Predictive Maintenance
  • Vehicle & Performance Tracking
  • Weather Forecasting
  • Route Planning
  • Aftermarket
  • Others

Pharmaceutical By Deployment Mode (USD Billion, 2025-2035)

  • On-Premise
  • On-Demand

Pharmaceutical By Application (USD Billion, 2025-2035)

  • Defense
  • Commercial Aerospace
  • Space

Pharmaceutical By Technology (USD Billion, 2025-2035)

  • Apps & Analytics
  • Cloud
  • Computer
  • Infrastructure Software
  • Networking
  • NoSQL
  • US Aerospace Big Data Analytics Market
  • SQL
  • Storage

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.